|
TDRKH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.237800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.483400E-01 |
| Normal-vs-Stage2 |
3.157800E-01 |
| Normal-vs-Stage3 |
3.034400E-01 |
| Normal-vs-Stage4 |
9.915200E-01 |
| Stage1-vs-Stage2 |
4.327000E-01 |
| Stage1-vs-Stage3 |
3.660200E-01 |
| Stage1-vs-Stage4 |
8.874000E-01 |
| Stage2-vs-Stage3 |
8.018200E-01 |
| Stage2-vs-Stage4 |
5.126000E-01 |
| Stage3-vs-Stage4 |
5.274400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.449000E-01 |
| Normal-vs-AfricanAmerican |
4.177000E-01 |
| Normal-vs-Asian |
3.162600E-01 |
| Caucasian-vs-AfricanAmerican |
9.145200E-01 |
| Caucasian-vs-Asian |
7.359000E-01 |
| AfricanAmerican-vs-Asian |
7.595200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.018000E-01 |
| Normal-vs-Female |
2.566800E-04 |
| Male-vs-Female |
1.97370999999169E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.506200E-01 |
| Normal-vs-Extreme_Weight |
2.719200E-01 |
| Normal-vs-Obese |
1.612400E-01 |
| Normal-vs-Extreme_Obese |
3.622200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.159030E-01 |
| Normal_Weight-vs-Obese |
9.836000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.560200E-01 |
| Extreme_Weight-vs-Obese |
1.597770E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.567600E-01 |
| Obese-vs-Extreme_Obese |
1.899630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.982260E-02 |
| Normal-vs-Age(41-60Yrs) |
7.753700E-02 |
| Normal-vs-Age(61-80Yrs) |
9.520200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.619560E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.966630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.134400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.098650E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.833500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.378100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.492000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.307800E-01 |
| Normal-VS-Type2 PRCC |
8.898400E-01 |
| Normal-VS-KIRP CIMP |
2.681900E-02 |
| Normal-VS-Unclassified PRCC |
3.282300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.534600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.756100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.802500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.149800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.414200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.385800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.889400E-01 |
| Normal-vs-N1 |
1.211250E-01 |
| Normal-vs-N2 |
8.256800E-01 |
| N0-vs-N1 |
6.925600E-02 |
| N0-vs-N2 |
7.041000E-01 |
| N1-vs-N2 |
6.587000E-01 |
|
|
